Controlling and conquering incurable metastatic cancer by targeting the major tumor-driving K-RAS/SIAH pathway activation to stratify patients, identify resistant tumor clones, quantify therapy efficacy, forecast tumor relapse, and predict patient survival in the neoadjuvant settings Meeting Abstract

author list

  • Tang, A. H., Lee, M. P., Lee, C. D., Lagever, A. C., Van Reesema, Siewertsz L. L., Collier, A. L., Iyer, A. S., Van Sciver, R. E., Svyatova, E., Kanda, K. F., Winston, J. S., Allen, C. A., Chang, D. Z., Petersen, G. M., Hoefer, R. A.


publication date

  • April 1, 2019


published in


start page

  • 146

end page

  • 147


  • 36


  • 2